Companies/VentriPoint Diagnostics Ltd.

Company profile

VentriPoint Diagnostics Ltd.

OTC: VPTDF · Healthcare · Medical - Devices

Canadian filerHQ Toronto, ONReports USD

#1013 of 1,394 Healthcare companies by revenuetop-quartile growth

EA Score

31D

FH 18DQ —GM 67SS 41

v0.1 · 45/100 weight · provisional

↑ revenue growth (YoY), 3-yr revenue growth · ↓ return on assets, workforce scale

Methodology →

Revenue TTM

$128.5k

Rev growth YoY (TTM)

+84.4%

Net income (FY)

-$2.3M

Employees

Market cap

$14.6M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$128.6k179.8k CAD2025

Net income-$2.3M-3.2M CAD2025

Operating income-$2.4M-3.4M CAD2025

Total assets$344.2k471.7k CAD2025

Liabilities$3.3M4.6M CAD2025

Equity-$3.0M-4.1M CAD2025

Revenue trend

FY2018 – FY2025 · USD

$46.4k

FY18

$61.1k

FY19

$26.9k

FY20

FY21

$52.4k

FY22

$36.4k

FY23

$69.5k

FY24

$128.6k

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

VentriPoint Diagnostics Ltd. booked $128.6k in FY2025 revenue, growing 85% year over year — faster than most Healthcare companies we track, at a -1778.6% net margin.

Peers · Healthcare

Lunai Bioworks Inc.21D BioVie Inc.——Cosmos Health Inc.55C HOOKIPA Pharma Inc.——

Key facts

CEOHugh MacNaught

SectorHealthcare

IndustryMedical - Devices

HeadquartersToronto, ON

ExchangeOTC: VPTDF

Employees3

IPO date2010-09-22

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.